Αποτελέσματα Αναζήτησης
25 Οκτ 2024 · santÉ ventures strategy We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.
- Team
Santé’s accomplished team combines financial judgment,...
- Portfolio
Santé fuels a diverse portfolio of innovative companies...
- Contact
We are persistently in search of new talent, technology,...
- Newsroom
ABK Biomedical Announces FDA IDE Stage 2 Approval for...
- Diane Brouillard
Diane is focused on creating and executing initiatives to...
- About
From identifying and funding promising healthcare companies...
- Team
Santé Ventures and Santé Capital are the two pillars of Santé, a firm that nurtures cutting-edge technologies to improve lives and generate returns. Santé has a history of investing in Biotech, Medtech, and Healthtech since 2006 and uses artificial intelligence to enhance its fund performance.
SANTÉ is a partnership that invests in early-stage healthcare companies across biotech, medtech, and healthtech industries. It also manages a public equity strategy that leverages machine learning and investment expertise. See its portfolio, updates, and events on LinkedIn.
Santé is a venture capital firm that invests in innovative ideas across science, medicine, and technology. Meet the Santé team, including the founding managing directors, partners, venture partners, and associates.
16 Σεπ 2021 · Santé Ventures, a firm that invests in early-stage Biotech, Healthtech, and Medtech companies, has closed its fourth fund with more than two-dozen LPs. The fund will build a portfolio of 15-25 innovative startups that can improve health outcomes and lower costs.
Sante Ventures is a venture capital firm that invests in early-stage healthcare and biotechnology companies in the US. Learn about its investment thesis, portfolio, founders, contacts, and similar companies on Crunchbase.
Santé Ventures is a venture capital investment firm based in Austin and Boston, founded in 2006. It invests in early-stage companies operating in the med-tech, biotechnology and health tech sectors in the US.
